{
  "slug": "illumina",
  "name": "Illumina, Inc.",
  "description": "Illumina, Inc. is a global leader in DNA sequencing and array-based technologies, providing innovative instruments, reagents, and services for genetic and genomic analysis. Their technologies are used in research, clinical, and applied markets to address complex challenges in biology.",
  "url": "https://optimly.ai/brand/illumina",
  "websiteUrl": null,
  "logoUrl": "https://logo.clearbit.com/https://facility.illumina.io/",
  "baiScore": 17,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Phantom",
  "archetype_status": "active",
  "category": "Biotechnology",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-07-26T00:02:22.917Z",
  "verifiedVitals": {
    "website": "https://www.illumina.com",
    "founded": "1998",
    "headquarters": "San Diego, California, USA",
    "pricing_model": "Capital equipment sales for sequencers, recurring revenue from consumable reagents, software licenses, service contracts.",
    "core_products": "DNA sequencing instruments, array platforms, reagents, software for genomic data analysis.",
    "key_differentiator": "Market leadership in next-generation sequencing (NGS) technology, high data accuracy and throughput, broad range of applications, and a comprehensive ecosystem of products and services.",
    "target_markets": "Research institutions, clinical diagnostic labs, academic centers, pharmaceutical companies, government labs, agricultural companies.",
    "employee_count": "Approximately 9,000 employees",
    "funding_stage": "Public Company (NASDAQ: ILMN)",
    "subcategory": "Genomics and DNA Sequencing"
  },
  "intentTags": {
    "problemIntents": [
      "Traditional Sanger Sequencing: While less efficient for large-scale projects, Sanger sequencing is a manual alternative for individual gene sequencing or validation.",
      "External Genomic Service Providers: Outsourcing sequencing and bioinformatics analysis to specialized service providers or Contract Research Organizations (CROs).",
      "Limited Genetic Analysis: Relying on older, less comprehensive genetic analysis methods, or foregoing large-scale genomic studies entirely due to lack of advanced sequencing capabilities."
    ],
    "solutionIntents": [
      "Illumina Analytics login",
      "Illumina DNA sequencing",
      "What does Illumina do?",
      "Alternative Bioinformatics Software: Using open-source or third-party bioinformatics tools for data analysis, separate from Illumina's ecosystem."
    ],
    "evaluationIntents": []
  },
  "timestamp": 1785238171082
}